申请人:Endo Pharmaceuticals, Inc.
公开号:US20140134250A1
公开(公告)日:2014-05-15
The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24 hours after dosing, as well as the tablet producing the sustained pain relief.